Work

Economic evaluation of sunitinib versus other new targeted therapies as first-line treatment of metastatic renal cell carcinoma (mRCC) in the United States

Year: 2009

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2009.27.15_suppl.e17556

Authors: A. Benedict, R. A. Figlin, C. Charbonneau, N. Kreif, S. Hariharan, S. Négrier

Institutions: City Of Hope National Medical Center, Pfizer (United States), United BioSource Corporation (United Kingdom), Centre Léon Bérard, City of Hope

Language: English

Topic: Health Systems, Economic Evaluations, Quality of Life

Subfield: Economics and Econometrics

Field: Economics, Econometrics and Finance

Domain: Social Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2982027901

Cites:

Cited by: 5

Related to: 10